The FDA and drug safety
DeCherney, G.S.
Delaware Medical Journal 70(9): 405-406
1998
ISSN/ISBN: 0011-7781 PMID: 9805408 Document Number: 486282
Document emailed within 1 workday
Related Documents
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Ecker-Schlipf, B. 1987: Disease and drug abuse. Current problems in drug safety Medizinische Monatsschrift für Pharmazeuten 10(8): 254-261
Leonard, B. 1987: Drug safety and drug toxicity: the Irish situation Irish Medical Journal 80(4): 106-107
Kimbel, K.H. 1978: Drug safety through drug legislation Der Internist 19(6): 326-332
Oberpichler-Schwenk, H. 2009: Heparin - an example in drug safety Medizinische Monatsschrift für Pharmazeuten 32(1): 1
Reilly, J. 2014: Drug testing & safety: what's the connection? Occupational Health and Safety 83(9): 80 82
Ovchinnikova, E.A.; Gerasimov, V.B. 2006: Drug safety: from development to clinical use Antibiotiki i Khimioterapiia 51(6): 15-22
Karande, S.; Gogtay, N.J.; Kshirsagar, N.A. 2003: Improving drug safety monitoring Indian Pediatrics 40(12): 1167-1175
Shatin, D.; Gardner, J.S.; Stergachis, A. 1999: Time for action on drug safety JAMA 281(4): 319
Scala, C.; Leone Roberti Maggiore, U.; Remorgida, V.; Venturini, P.L.; Ferrero, S. 2013: Drug safety evaluation of desogestrel Expert Opinion on Drug Safety 12(3): 433-444
Hagemann, U.; Grase, R.; Thiele, A.; Bass, R.; Schönhöfer, P.S. 1982: Problems of drug safety: aristolochic acid Münchener Medizinische Wochenschrift 124(25): 611-612
Sharma, D.C.; Jha, J.; Sharma, P.; Gaur, B.L. 2001: Evaluation of safety and efficacy of a gold containing Ayurvedic drug Indian Journal of Experimental Biology 39(9): 892-896
Abdalla, A.; Mazur, N.A.; Shestakova, N.V.; Nazarenko, V.A. 1991: Assessment of the efficacy and safety of class IC antiarrhythmic drug combinations Terapevticheskii Arkhiv 63(1): 56-59
McCracken, J.T. 2005: Safety issues with drug therapies for autism spectrum disorders Journal of Clinical Psychiatry 66(Suppl 10): 32-37
Mustafaoglu, F.; Petrakova, L.N.; Pershukov, I.V.; Batyraliev, T.A.; Pia, I.V.; Lazarev, I.A.; Ramazanov, D.M.; Shul'zhenko, L.V.; Kadyrov, B.K.; Sal'nikov, D.V.; Dolgikh, N.N.; Sidorenko, B.A. 2008: Efficacy and safety of enoxaparin use during drug-eluting stents implantation Kardiologiia 48(6): 28-34
Pryce, C.; Pierre, R.B.; Steel-Duncan, J.; Evans-Gilbert, T.; Palmer, P.; Moore, J.; Rodriguez, B.; Christie, C.D.C. 2008: Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS West Indian Medical Journal 57(3): 238-245
Jabłecka, A.; Korzeniowska, K. 2010: The safety of pharmacotherapy in the light of monitoring adverse drug reaction Przeglad Lekarski 67(10): 1091-1092
Maksimov, V.A.; Logvinov, L.A.; Danovich, V.M.; Kumachev, K.V.; Cherniatin, A.A. 2009: Clinical efficacy and safety of the drug "Likoprofit potential-formula" Urologiia 6: 56-59